Showing results (41-50 of 2,405) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|February 23, 2018
Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety resultsPhilip S Wells, Anthonie W A Lensing, Lloyd Haskell, et al.Journal of Medical Economics|October 20, 2017
Real-world comparison of all-cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for non-valvular atrial fibrillation patients prescribed oral anticoagulants in a US health planAlpesh Amin, Allison Keshishian, Lien Vo, et al.Journal of Medical Economics|December 15, 2018
Hospital patients with severe wounds: early evidence on the impact of Medicare payment changes on treatment patterns and outcomesBerna Demiralp, Samuel Soltoff, Lane KoenigJournal of Medical Economics|December 15, 2018
Decrease in American birth rates makes it imperative for the United States to implement state mandated fertility coverageSamer Tannus, Michael H DahanJournal of Medical Economics|December 19, 2018
Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong KongJune W Y Choon, David B C Wu, H Y Chong, et al.Journal of Medical Economics|June 11, 2020
Subscriber continuity in health insurance plans: factors associated with re-enrollment and coverage changesMelissa H Roberts, Xuanhao He, Claudia Díaz Fuentes, et al.Journal of Medical Economics|April 29, 2021
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US populationJeffrey S Berger, François Laliberté, Akshay Kharat, et al.Journal of Medical Economics|May 14, 2021
Modelling the value of innovative treatments for Alzheimer's disease in the United StatesCharles Makin, Peter Neumann, Sue Peschin, et al.Journal of Medical Economics|May 10, 2021
Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in SwedenCarlos Acosta, Mattia Gianinazzi, Thibaut Dort, et al.Journal of Medical Economics|June 26, 2020
Clinical and economic burden of postsurgical complications of high-risk surgeries: a cohort study in ThailandKhachen Kongpakwattana, Piyameth Dilokthornsakul, Teerapon Dhippayom, et al.Pageof 241